ASCO President David Johnson to oncologists: It’s time to “reconnect to our patients” and “recommit to our profession.” Horning outlines priorities.
Von Eschenbach says oncology is undergoing a “revolutionary evolution.”
CCOPs ask NCI officials about one-year extensions.
Varmus: Why are scientific societies obstructing public access to research results?
Despite NCI director’s enthusiasm, “We have a long way to go before we beat cancer,” the former NIH director says.
Onward to 2010? NCI promises faster progress for more money.
Trending Stories
- As his Senate testimony alleged danger from mRNA COVID vaccine, El-Deiry had an offer to run NCI Frederick lab
The job offer to run the lab—home to virus research, RAS Initiative, and data science—was quickly rescinded - Proposed OMB rule aims at the heart of the U.S. research enterprise—and scientists are fighting back
“The question isn’t whether politics will influence research. Under this proposal, that’s the point. That’s their goal.” - Pancreatic cancer breakthrough came from smart scientists making smart bets—not from politicization of science
- House bill gives NCI $7.4 billion in FY 2027—$110 million above current budget
- NIH calls for comment on proposal to limit the number of RPGs per PI
- Lessons from the AIDS Quilt: what the cancer world can learn from AIDS advocacy
